Charles River Adds New Biologics-Testing Facility

Mar 16, 2018
By Pharmaceutical Technology Editors

On March 8, 2018, Charles River Laboratories, a contract research organization, announced the addition of a new 73,000-square-foot facility on Devon Park Road in Wayne, PA, that will more than double the laboratory space available at the company’s existing facilities in Malvern and King of Prussia, PA.

This latest announcement is one of several expansions made to the company’s biologics testing solutions infrastructure to support the characterization, development, and release of biologics and biosimilars.

Certain laboratory operations conducted at the Malvern and King of Prussia sites will begin to move to Devon Park early in the third quarter of 2018. The formal transfer of assays will be done in phases, and, during the transition, both the Malvern and King of Prussia facilities will remain fully operational.

“The high volume of biologics and biosimilars in development has led to a rapid increase in demand for our services,” said Greg Beattie, corporate vice president, Global Biologics Testing Solutions at Charles River, in a company press release. “The continued expansion of our [b]iologics service portfolio and additional capacity will further enhance our ability to support clients’ development efforts from discovery through clinical phases and commercial manufacturing.”

Source: Charles River Laboratories 

native1_300x100
lorem ipsum